Literature DB >> 18549814

Gastric mucosal defense and cytoprotection: bench to bedside.

Loren Laine1, Koji Takeuchi, Andrzej Tarnawski.   

Abstract

The gastric mucosa maintains structural integrity and function despite continuous exposure to noxious factors, including 0.1 mol/L HCl and pepsin, that are capable of digesting tissue. Under normal conditions, mucosal integrity is maintained by defense mechanisms, which include preepithelial factors (mucus-bicarbonate-phospholipid "barrier"), an epithelial "barrier" (surface epithelial cells connected by tight junctions and generating bicarbonate, mucus, phospholipids, trefoil peptides, prostaglandins (PGs), and heat shock proteins), continuous cell renewal accomplished by proliferation of progenitor cells (regulated by growth factors, PGE(2) and survivin), continuous blood flow through mucosal microvessels, an endothelial "barrier," sensory innervation, and generation of PGs and nitric oxide. Mucosal injury may occur when noxious factors "overwhelm" an intact mucosal defense or when the mucosal defense is impaired. We review basic components of gastric mucosal defense and discuss conditions in which mucosal injury is directly related to impairment in mucosal defense, focusing on disorders with important clinical sequelae: nonsteroidal anti-inflammatory drug (NSAID)-associated injury, which is primarily related to inhibition of cyclooxygenase (COX)-mediated PG synthesis, and stress-related mucosal disease (SRMD), which occurs with local ischemia. The annual incidence of NSAID-associated upper gastrointestinal (GI) complications such as bleeding is approximately 1%-1.5%; and reductions in these complications have been demonstrated with misoprostol, proton pump inhibitors (PPIs) (only documented in high-risk patients), and COX-2 selective inhibitors. Clinically significant bleeding from SRMD is relatively uncommon with modern intensive care. Pharmacologic therapy with antisecretory drugs may be used in high-risk patients (eg, mechanical ventilation >or=48 hours), although the absolute risk reduction is small, and a decrease in mortality is not documented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18549814     DOI: 10.1053/j.gastro.2008.05.030

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  181 in total

1.  Gastroprotective activity of carvacrol on experimentally induced gastric lesions in rodents.

Authors:  Irisdalva S Oliveira; Francilene V da Silva; Ana Flávia S C Viana; Márcio R V dos Santos; Lucindo J Quintans-Júnior; Maria do Carmo C Martins; Paulo H M Nunes; Francisco de A Oliveira; Rita de C M Oliveira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-06-28       Impact factor: 3.000

Review 2.  Recent advances in gut nutrient chemosensing.

Authors:  C A Nguyen; Y Akiba; J D Kaunitz
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

3.  Effects of lansoprazole on the expression of VEGF and cellular proliferation in a rat model of acetic acid-induced gastric ulcer.

Authors:  Shun Kobayashi; Noriko Nakajima; Yoko Ito; Mitsuhiko Moriyama
Journal:  J Gastroenterol       Date:  2010-03-24       Impact factor: 7.527

Review 4.  Safety concerns over the use of intestinal permeation enhancers: A mini-review.

Authors:  Fiona McCartney; John P Gleeson; David J Brayden
Journal:  Tissue Barriers       Date:  2016-04-12

5.  Local protective effects of oral 45S5 bioactive glass on gastric ulcers in experimental animals.

Authors:  Ai-niu Ma; Nian Gong; Jin-miao Lu; Jin-lu Huang; Bin Hao; Yang Guo; Jipin Zhong; Yuhong Xu; Jiang Chang; Yong-xiang Wang
Journal:  J Mater Sci Mater Med       Date:  2013-01-18       Impact factor: 3.896

6.  Suppression of hypothalamo-hypophyseal-adrenocortical system function as the cause of aggravation of the ulcerogenic action of indomethacin on the stomach after administration of pharmacological doses of hydrocortisone.

Authors:  O Yu Morozova; T R Bagaeva; L P Filaretova
Journal:  Neurosci Behav Physiol       Date:  2009-12-11

7.  Effect of selenium and grape seed extract on indomethacin-induced gastric ulcers in rats.

Authors:  Amr M Abbas; Hussein F Sakr
Journal:  J Physiol Biochem       Date:  2013-03-01       Impact factor: 4.158

8.  Effects of pantoprazole on ulcer healing delay associated with NSAID treatment.

Authors:  Matteo Fornai; Rocchina Colucci; Luca Antonioli; Narcisa Ghisu; Marco Tuccori; Corrado Blandizzi; Mario Del Tacca
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-14       Impact factor: 3.000

9.  NSAID-induced injury of gastric epithelial cells is reversible: roles of mitochondria, AMP kinase, NGF, and PGE2.

Authors:  Amrita Ahluwalia; Neil Hoa; Michael K Jones; Andrzej S Tarnawski
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

10.  Gastric carcinogenesis.

Authors:  Ismail Gomceli; Baris Demiriz; Mesut Tez
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.